Lynparza

AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US
Yahoo
Wed, 03/29/17 - 09:05 am
AstraZeneca
Lynparza
olaparib
ovarian cancer
AZ gears up for FDA filing as PARP inhibitor Lynparza wins big in ovarian cancer trial
Fierce Pharma
Tue, 03/14/17 - 04:43 pm
AstraZeneca
PARP inhibitors
Lynparza
FDA
ovarian cancer
clinical trials
Clovis, Tesaro Soar on Astrazeneca Phase Three News
TheStreet.com
Sat, 02/18/17 - 02:37 pm
Clovis Oncology
Tesaro
AstraZeneca
clinical trials
Lynparza
breast cancer
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
TheStreet.com
Fri, 02/17/17 - 11:02 am
AstraZeneca
Lynparza
breast cancer
Clovis Falls on Fears Ovarian Cancer Drug Inferior to Competition
TheStreet.com
Fri, 10/7/16 - 04:55 pm
Clovis Oncology
ovarian cancer
rucaparib
Lynparza
AstraZeneca
An Overnight Double! Could These Drugmakers Be Next?
Motley Fool
Sat, 07/2/16 - 12:36 pm
Tesaro
ovarian cancer
PARP inhibitors
niraparib
AstraZeneca
Lynparza
Medivation
AbbVie
Clovis Oncology
LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
Yahoo
Mon, 06/6/16 - 10:31 am
Lynparza
olaparib
ovarian cancer
AstraZeneca
ASCO 2016
AstraZeneca looks to DNA damage-response drugs for edge in oncology
BioPharma Dive
Tue, 05/17/16 - 09:25 am
AstraZeneca
oncology
ASCO
Lynparza
AstraZeneca chief chalks up milestones on his map to $45B
Fierce Pharma
Thu, 01/21/16 - 05:53 pm
AstraZeneca
Pascal Soriot
Lynparza
Tagrisso
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
Fierce Biotech
Fri, 10/30/15 - 11:17 am
AstraZeneca
olaparib
Lynparza
prostate cancer
ovarian cancer
AstraZeneca Has An Oncology Pipeline Packed With Potential
Seeking Alpha
Sun, 07/19/15 - 05:51 pm
AstraZeneca
oncology
AZD9291
Lynparza
Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
TheStreet.com
Mon, 06/1/15 - 09:41 am
Clovis Oncology
ASCO
rucaparib
AstraZeneca
Lynparza
rociletinib
AZD9291
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
Forbes
Mon, 05/4/15 - 08:54 am
Lynparza
cancer
BRCA
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
AstraZeneca's ovarian cancer drug gets U.S. approval
Yahoo/Reuters
Fri, 12/19/14 - 04:01 pm
AstraZeneca
Lynparza
ovarian cancer
FDA
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Yahoo/Reuters
Thu, 12/18/14 - 09:01 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Fri, 10/24/14 - 07:31 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib

Pages